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The histone code reader Spin1 controls skeletal muscle
development
Holger Greschik1, Delphine Duteil1, Nadia Messaddeq2, Dominica Willmann1, Laura Arrigoni3, Manuela Sum1, Manfred Jung4,5,
Daniel Metzger2, Thomas Manke3, Thomas Günther1 and Roland Schüle*,1,5,6
While several studies correlated increased expression of the histone code reader Spin1 with tumor formation or growth, little is
known about physiological functions of the protein. We generated Spin1M5 mice with ablation of Spin1 in myoblast precursors
using the Myf5-Cre deleter strain. Most Spin1M5 mice die shortly after birth displaying severe sarcomere disorganization and
necrosis. Surviving Spin1M5 mice are growth-retarded and exhibit the most prominent defects in soleus, tibialis anterior, and
diaphragm muscle. Transcriptome analyses of limb muscle at embryonic day (E) 15.5, E16.5, and at three weeks of age provided
evidence for aberrant fetal myogenesis and identified deregulated skeletal muscle (SkM) functional networks. Determination of
genome-wide chromatin occupancy in primary myoblast revealed direct Spin1 target genes and suggested that deregulated basic
helix-loop-helix transcription factor networks account for developmental defects in Spin1M5 fetuses. Furthermore, correlating
histological and transcriptome analyses, we show that aberrant expression of titin-associated proteins, abnormal glycogen
metabolism, and neuromuscular junction defects contribute to SkM pathology in Spin1M5 mice. Together, we describe the first
example of a histone code reader controlling SkM development in mice, which hints at Spin1 as a potential player in human SkM
disease.
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Spindlin1 (Spin1) is a histone code reader binding histone H3
trimethylated at lysine 4 (H3K4me3) with high affinity.1–3
H3K4me3 association is enhanced by the presence of
asymmetrically dimethylated arginine 8 of histone H34. Spin1
is highly expressed in several types of tumors5–7 and affects
cell cycle, chromatin segregation, apoptosis, and transforma-
tion of cell lines, as well as tumor formation in nude mice.6,8–11
While these studies suggest important roles in cancer,
physiological functions of Spin1 have only been subject to
initial investigation. Mouse oocytes deficient for maternal
Spin1 undergo normal folliculogenesis, but fail to resume
meiosis.12 Furthermore, mice with ubiquitous Spin1 ablation
die shortly after birth.12 However, tissue-restricted defects
accounting for postnatal death have not been reported.
Skeletal muscle (SkM) is the most abundant tissue in
vertebrates mediating support and movement and contribut-
ing to overall metabolism. SkM development is orchestrated
by key transcription factors including Pax3 and Pax7, which
are also required for muscle stem cell specification,13,14 and
the myogenic regulatory factors (MRFs) Myf5, MyoD (Myod1),
Mrf4 (Myf6), and myogenin (Myog).13–15 MRFs are tissue-
specific basic helix-loop-helix (bHLH) transcription factors
acting as homodimers or as heterodimers with other bHLH
transcription factors such as the ubiquitously expressed
E-proteins E12/E47 (Tcf3), E2-2/ITF2 (Tcf4), and HEB/HTF4
(Tcf12).14
SkM fiber formation in mice comprises three successive
phases, an embryonic wave from around embryonic day (E)
10.5 to E12.5, a fetal wave from around E14.5 to E17.5,
and a postnatal period during which adult fibers are
established.14,16–18 Adult myofibers exhibit distinct contractile
properties (slow- or fast-twitch), patterns of innervation, and
metabolic activities (oxidative or glycolytic), which correlate
with the expression of specific myosin heavy chain (MHC)
isoforms.19,20 Limb muscle of adult mice is composed of type I
(slow, oxidative), type IIa (fast, oxidative), type IIx (fast,
glycolytic), and type IIb (fast, glycolytic) fibers.19,20 SkM mass
and functions become compromised in disease and numerous
gene mutations causing myopathies or muscular dystrophies
have been documented.21–28 Interestingly, selected fiber or
muscle types preferentially degenerate in certain disease
states.29,30
In this study, we crossed mice harboring conditional Spin1
alleles (Spin1p/p) with theMyf5-Cre deleter strain31 to ablate Spin1
in myogenic precursors. Most homozygous Spin1p/p Myf5-Cre
(hereafter termed Spin1M5) mice die shortly after birth, while
surviving mice display severe growth retardation. Histological,
transcriptome, and cistrome analyses provide evidence
for aberrant fetal myogenesis and deregulated basic
bHLH transcription factor networks around the onset of SkM
defects. Furthermore, our observations suggest that altered
expression of titin-associated proteins, aberrant glycogen
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metabolism, and defective NMJs contribute to SkM pathology
in Spin1M5 mice. In summary, our data reveal a severe
developmental defect caused by ablation of a histone code
reader in SkM and hint at Spin1 as a potential player in human
SkM disease.
Results
Loss of Spin1 in SkM results in postnatal lethality. To
investigate physiological functions of Spin1 in vivo, we
generated ubiquitous knockout (Spin1R26) mice by crossing
Spin1p/p mice with the Rosa26-Cre deleter strain32
(Supplementary Figure 1a). Spin1R26 mice were born, but
died within one day after birth (Supplementary Figure 1b),
which is in agreement with observations by others.12 Of note,
at E18.5 Spin1R26 mice displayed dropping forelimbs
(Figure 1a) indicating a neuromuscular defect.33
To address potential functions of Spin1 in SkM, we analyzed
Spin1 protein expression in hind limb sections of control mice
at E15 and after birth (P0) by immunofluorescence. At both
time points, we observed intense Spin1 staining in Pax7-
positive myoblast precursors (Figure 1b (arrowheads)) and
weaker staining in nuclei of myofibers (Figure 1c (arrow-
heads)). Of note, in newborn mice, Spin1 expression was
undetectable in some nuclei of myofibers (Figure 1c, bottom
row (arrows)).
Next, we deleted Spin1 in myoblast precursors by crossing
Spin1p/p mice with the Myf5-Cre deleter strain31 resulting in
Spin1M5 mice. Immunostaining confirmed the absence of
Spin1 protein in nuclei of Pax7-positive myoblast precursors
(Figure 1d (arrowheads); Supplementary Figure 1c) and
myofibers of Spin1M5 fetuses (Figure 1e (arrowheads);
Supplementary Figure 1d). Remaining Spin1 staining is due
to expression in non-myogenic cells such as Tcf4-positive
fibroblasts34 (Supplementary Figure 1e (arrowheads); see
Materials and Methods and Supplementary Figure 1f, g for
further characterization).
Homozygous Spin1M5 mice were obtained at the expected
Mendelian ratio at birth (Supplementary Figure 1h). However,
about 80% of Spin1M5 mice died within one day after birth.
Newborn Spin1M5 mice could typically be distinguished from
control littermates by an abnormal posture and the absence of
milk in the stomach (Figure 1f). Moreover, at E16.5, we
observed dropping forelimbs for Spin1M5 fetuses (Figure 1g).
Together, our data show that ablation of Spin1 in SkM causes
early postnatal death of the majority of mice.
SkM of Spin1M5 mice is characterized by necrosis and
structural defects in non-necrotic fibers. To characterize
SkM defects in Spin1M5 mice, we inspected hematoxylin &
eosin (H&E)-stained hind limb sections at different stages of
development. Compared with control littermates, we
observed in newborn Spin1M5 mice loss of fibers
(Figure 2a, top row (black asterisks)) and numerous
immature or degenerating fibers lacking contractile material
(dashed circles). In Spin1M5 fetuses at E16.5, we also noted
fibers with irregular H&E staining (Figure 2a, middle row
(dashed circles)) and at E15 enlarged fibers, which were less
abundant in control samples (Figure 2a, bottom row (white
asterisks)).
Electron microscopy analyses of hind limb sections
revealed for newborn Spin1M5 mice degenerating, necrotic
fibers (Figure 2b, columns I–II (demarcated by dashed lines)),
defective mitochondria (Figure 2b, column III (arrows)), and
abnormal glycogen accumulation (Figure 2b, column IV
(asterisks)). Similar defects were detected for Spin1M5 fetuses
at E16.5 (Supplementary Figure 2). Furthermore, in non-
necrotic fibers of Spin1M5 fetuses, we observed structural
defects including a low density of contractile material and the
lack of a clear M-line (Supplementary Figure 2, column III
(triangles)). Together, our H&E and electron microscopy
analyses uncovered necrotic and structurally defective fibers
in Spin1M5 mice. In addition, the data suggested an onset of
SkM defects before E16.5.
Transcriptome and histological analyses provide evi-
dence for aberrant fetal myogenesis in Spin1M5 mice. To
investigate alterations of the transcriptome in SkM of Spin1M5
fetuses, we performed RNA sequencing (RNA-seq) analyses
using RNA isolated from limb muscle. At E15.5, we observed
only 17 differentially expressed genes (DEGs) (P≤1e−3; fold
change ≥1.5) (Figure 3a; Supplementary Table 1a). In
comparison, at E16.5 RNA-seq detected 193 DEGs, of which
seven (Ankrd1, Ankrd2, Pmaip1, Scn4b (upregulated); Myf5,
Msc, Nos1 (downregulated)) overlapped with the E15.5 DEGs
(Figure 3a; Supplementary Table 1b). The strong increase in
DEGs from E15.5 to E16.5 provided evidence for E15.5 as the
approximate onset of SkM defects in Spin1M5 fetuses.
The common E15.5/E16.5 DEGs Ankrd1 (CARP) and
Ankrd2 (ARPP) encode titin-associated regulators of sarco-
mere function, whose expression is often deregulated in SkM
disease.35 We therefore investigated Ankrd1 and Ankrd2
protein levels in hind limb sections of E16.5 fetuses by
immunofluorescence (Figures 3b and c). Most prominently, in
control fetuses, expression of both proteins was restricted to
the inner (prospective oxidative) part of the tibialis anterior (TA)
neighboring the tibia (Figure 3c (demarcated by dashed
lines)), whereas in Spin1M5 fetuses staining was also present
in the outer (prospective glycolytic) part of the TA (Figure 3c
(asterisks)). In comparison, at E15 Ankrd1 and Ankrd2
staining of hind limb muscle of Spin1M5 and control
mice was similar (Supplementary Figures 3a and b). Thus,
Figure 1 Loss of Spin1 in SkM results in postnatal lethality. (a) Dropping forelimbs (arrow) indicating a neuromuscular defect observed in ubiquitous Spin1 knockout
(Spin1R26) but not Spin1+/+ (Ctrl) fetuses. (b,c) Immunofluorescence (IF) staining of hind limb sections of control fetuses at E15 and of newborn mice (P0) with antibodies directed
against Spin1 (green), Pax7 (red), or myosin heavy chain (MHC) (red). Arrowheads mark nuclei of myogenic precursors coexpressing Spin1 and Pax7 (b) or Spin1-positive nuclei
in myofibers (c). Arrows depict nuclei devoid of Spin1 staining in myofibers at P0 (c). (d,e) IF staining of hind limb sections of Spin1M5 fetuses at E15 with the indicated antibodies.
Loss of Spin1 expression in Pax7-positive nuclei of myogenic precursors (d) or myofibers (e) in Spin1M5 fetuses is highlighted with arrowheads. (b-e) Nuclei were visualized with
DAPI (blue). (f) Absence of milk in the stomach (arrows) and an abnormal posture observed in newborn Spin1M5 mice but not control littermates. (g) Dropping forelimbs (arrow)
observed in Spin1M5 but not control fetuses
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deregulation of Ankrd1 and Ankrd2 transcripts at E15.5 and
E16.5 and aberrant protein expression at E16.5 are early
markers of SkM defects in Spin1M5 fetuses.
To analyze which proportion of developmentally regulated
genes is affected by the absence of Spin1, we compared the
E16.5 DEGs with gene expression changes in control fetuses
from E15.5 to E16.5. In control fetuses, we observed 2042
genes differentially expressed between E15.5 and E16.5
(Figure 3d; Supplementary Table 1c). Phenotype and pathway
analyses for these 2042 DEGs using WebGestalt36 confirmed
relevance of the identified genes for SkM development or
function (Supplementary Figures 3c and d). Intersection with
the 193 E16.5 DEGs revealed an overlap of 125 genes
(Figure 3d). Therefore, the absence of Spin1 prevents
adequate expression of a subset of genes regulated during
the fetal phase of myogenesis in control mice.
To corroborate aberrant fetal myogenesis in Spin1M5 mice,
we compared the E16.5 DEGs with transcripts previously
observed to be differentially expressed in embryonic or fetal
myotubes.37 Of the 27 transcripts more highly expressed in
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Figure 2 SkM of Spin1M5 mice is characterized by necrosis and structural defects in non-necrotic fibers. (a) Hematoxylin and eosin (H&E) staining of transversal tibialis
anterior sections of Spin1M5 and control mice at P0, E16.5, and E15. Fiber loss in Spin1M5 mice is indicated by black asterisks (top row), fibers with irregular H&E staining are
encircled, and unusually large fibers more frequently observed in Spin1M5 than in control fetuses at E15 are marked with white asterisks (bottom row). (b) Electron microscopy
(EM) images of SkM samples of newborn (P0) Spin1M5 and control mice. Dashed lines demarcate degenerating, necrotic fibers (I–II, bottom), arrowheads mark normal
mitochondria (III, top), arrows point at defective mitochondria (III, bottom), and asterisks indicate abnormal glycogen accumulation (IV, bottom)
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embryonic (compared with fetal) myotubes, only one (Tnnc1)
overlapped with the E16.5 DEGs (Figure 3e). Importantly,
eight out of thirteen transcripts more highly expressed in fetal
myotubes (Myh8, Tnni2, Tnnt3, Atp2a1, Casq1, Pvalb, Ckm,
and Eno3) were downregulated DEGs in Spin1M5 mice at
E16.5 (Figure 3e). Together, our data provided evidence for an
impaired progression of fetal myogenesis in Spin1M5 mice.
Identification of deregulated SkM functional networks in
Spin1M5 fetuses. To identify genes accounting for SkM
defects in Spin1M5 fetuses, we performed phenotype and
pathway analyses for the E16.5 DEGs using WebGestalt36
(Figures 4a and b). These analyses revealed terms related to
SkM function, metabolism, and pathology. We grouped the
genes associated with the phenotype and pathway terms
according to functional networks previously proposed in
systems biology analyses for SkM38,39 (Figure 4c). The
deregulated SkM networks comprise genes encoding tran-
scription factors and signaling molecules, proteins important
for sarcomere function, titin (Ttn)-associated factors, meta-
bolic enzymes, and proteins involved in the neuromuscular
junction (NMJ) and excitation-contraction coupling (ECC)
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Figure 3 Transcriptome and histological analyses provide evidence for aberrant fetal myogenesis in Spin1M5 mice. (a) Intersection of differentially expressed genes (DEGs)
observed for SkM of Spin1M5 and control fetuses at E15.5 (yellow) and E16.5 (red). (R: enrichment factor; p: P-value calculated for the intersection.) (b) Schematic representation
of the hind limb section depicting tibialis anterior (TA), extensor digitorum longus (EDL), and tibia analyzed in c. Prospective oxidative or glycolytic parts of the TA (demarcated by a
dashed line) are located proximal or distal to the tibia, respectively. (c) Detection of Ankrd1 or Ankrd2 (green) by immunofluorescence (IF) staining in transversal hind limb sections
of Spin1M5 and control fetuses at E16.5. Muscle fibers were visualized with myosin heavy chain (MHC) antibody (red), nuclei were stained with DAPI (blue). Dashed lines
demarcate areas with or without Ankrd1 or Ankrd2 expression in control fetuses. Asterisks mark regions of the TA of Spin1M5 fetuses, in which Ankrd1 or Ankrd2 are aberrantly
expressed. (d) Intersection of the E16.5 DEGs (red) with genes differentially expressed in control fetuses at E15.5 and E16.5 (green). (e) Comparison of the E16.5 DEGs (red)
with transcripts reported to be more highly expressed in either embryonic or fetal myotubes (MTs, cyan)37
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(Figure 4c). Deregulation of these functional networks likely
causes SkM dysfunction in Spin1M5 fetuses.
Deregulated basic helix-loop-helix transcription factor
networks account for SkM defects in Spin1M5 fetuses. In
addition to genes required for SkM structure or function, we
found the myogenic bHLH transcription factor-encoding
genes Myf5, Myog, Msc (musculin, MyoR), and Hes615,40–43
among the E16.5 DEGs (Figure 4c (network 'transcription
and signaling')). Therefore, deregulated bHLH transcription
factor-controlled gene expression may be an early event
accounting for aberrant myogenesis in Spin1M5 fetuses. In
support of this idea, Myf5 and Msc were also among the
E15.5 DEGs (Supplementary Table 1a).
To correlate gene expression with Spin1 chromatin occu-
pancy, we performed chromatin immunoprecipitation followed
by massive parallel sequencing (ChIP-seq) using primary
myoblasts. ChIP-seq with Spin1-specific antibody revealed
17106 peaks, of which the majority (61.2%) was located at the
promoters (transcription start site (TSS)±1 kb) of 12438
genes (Figure 5a; Supplementary Figure 4a). Next, ChIP-
seq analysis for H3K4me3 detected 37% of the peaks at the
promoters of 14832 genes (Figure 5a; Supplementary
Figure 4a). Further analyses confirmed the presence of
H3K4me3 at almost all gene promoters occupied by Spin1
(Figure 5a) as well as overlapping intensity profiles
(Figure 5b). Thus, in primary myoblasts Spin1 and
H3K4me3 occupy a large portion of cellular gene promoters.
Despite occupying thousands of gene promoters, Spin1
apparently only regulates a subset of target genes during fetal
myogenesis. To further investigate Spin1-mediated gene
regulation, we intersected the E16.5 DEGs with the cistrome
observed in primary myoblasts. This analysis revealed the
presence of Spin1 and H3K4me3 at the promoter of 88 E16.5
DEGs (Figure 5a). A transcription factor target analysis for
these 88 genes using WebGestalt36 revealed a significant
enrichment of potential Myod1 target genes followed by E12
(Tcf3) and Mef2 targets (Figure 5c).
To validate Myod1 promoter occupancy of Spin1 target
genes, we analyzed a previously deposited Myod1 ChIP-
seq data set for C2C12 myoblasts (GEO data set
GSE36024), which uncovered Myod1 peaks at the promo-
ters of 14612 genes (Figure 5d). Intersection with Spin1-
occupied genes showed a large overlap of 11695 direct
targets of Spin1 and Myod1 (Figure 5d). Comparison with
the E16.5 DEGs identified 82 direct Spin1/Myod1 targets
(Figure 5d). Inspection of ChIP-seq tracks confirmed the
presence of Spin1, H3K4me3, and Myod1 at promoters
of SkM functional, metabolic, and regulatory genes
(Supplementary Figure 4b) as well as the promoters of
Myf5, Myod1, Myog, Msc, and Hes6 (Figure 5e). Together,
our data suggest that deregulated bHLH transcription
factors affect Spin1/Myod1-dependent target gene tran-
scription thereby accounting, at least in part, for SkM
defects in Spin1M5 fetuses.
Surviving Spin1M5 mice exhibit major defects in soleus,
tibialis anterior, and diaphragm. While the majority of
Spin1M5 mice died shortly after birth, about 20% survived and
reached adulthood. We next investigated the consequences
of aberrant fetal myogenesis for SkM in surviving Spin1M5
mice between 15 and 30 weeks of age, the latter representing
the oldest cohort obtained. Adult Spin1M5 mice exhibit a
severe scoliosis, cachexia, and weigh only around 60% of
control littermates (Figures 6a and b).
Inspection of hind limb muscles revealed as the most
prominent feature an abnormally thin and pale soleus (SOL)
muscle in Spin1M5 mice (Figure 6c). Other hind limb muscles
(gastrocnemius (GC), plantaris (PL), TA, extensor digitorum
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Figure 4 Identification of deregulated SkM functional networks in Spin1M5
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longus (EDL), and quadriceps (QC)) also displayed a reduced
mass relative to controls (Figure 6d; Supplementary
Figure 5a). Themuscle mass reduction wasmore pronounced
(about 60%) for TA than for gastrocnemius-plantaris, EDL, or
quadriceps (about 30%) (Supplementary Figure 5a). Counting
showed that the number of TA fibers was reduced by about
50%, but did not uncover a significant difference for the EDL
of Spin1M5 compared with control mice (Supplementary
Figure 5b).
H&E staining confirmed degeneration of the soleus as
evidenced by rounded fibers, enormous differences in fiber
diameters, and the presence of inflammatory cells (Figure 6e).
Major defects were also observed in the TA, while gastro-
cnemius and EDL appeared largely normal (Figure 6e). Also,
the diaphragm (DP) of Spin1M5 mice displayed severe muscle
fiber degeneration (Supplementary Figure 5c). Gomori stain-
ing detected abnormal collagen deposition indicating fibrosis
mainly in the soleus and TA muscle of Spin1M5 mice
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(Supplementary Figure 5d). Together, our observations
revealed severe defects in soleus, TA, and diaphragm.
To investigate whether degenerative changes affected
specific fiber types, we analyzed SkM sections by immuno-
fluorescence. The TA of control mice exhibited typical fiber
type compositions, that is, mainly type IIb fibers in white
(primarily glycolytic) TA and type IIa and IIx fibers in red
(primarily oxidative) TA (Figure 6f, top and middle rows).
NADH staining correlated with the glycolytic or oxidative
properties of the fiber types (Figure 6f, bottom row). In
comparison, in the TA of some Spin1M5 mice, fiber types could
not be clearly distinguished since most fibers expressed
varying levels of MHC-IIx, in part together with MHC-IIb
(Figure 6f).We rarely observed type IIa fibers in the TA of these
animals (Figure 6f). However, in the TA of other Spin1M5 mice
type IIa fibers were present (Supplementary Figure 5e, right
column). Furthermore, all expected fiber types were observed
in the degenerating soleus and the neighboring plantaris of
Spin1M5 mice (Supplementary Figure 5e, left and middle
columns), although defective fibers could be identified by
irregular fiber size, shape, or NADH staining (Figure 6f;
Supplementary Figure 5e, bottom row (arrows)). Overall,
these observations argue against selective fiber type degen-
eration in Spin1M5 mice, but rather suggest that certain
muscles including soleus, TA, and diaphragm degenerate.
Identification of deregulated SkM functional networks in
surviving Spin1M5 mice. We next analyzed the transcrip-
tomes of TA of Spin1M5 and control mice at three weeks of
age (P21), which revealed 1040 DEGs (P≤ 1e−5; fold
change ≥1.5; Figure 7a; Supplementary Table 1d). Intersec-
tion with the E16.5 DEGs detected a highly significant overlap
of 50 genes (Figure 7a) suggesting that defects in surviving
Spin1M5 mice are related to differential gene expression at
early stages of disease.
Phenotype and pathway analyses for the P21 DEGs
uncovered terms related to muscle function and disease, as
well as metabolism (Figures 7b and c). In addition, we noted
terms such as ‘focal adhesion’ and ‘regulation of actin
cytoskeleton’, which were not identified at E16.5 (Figures 4a
and b). Grouping of the P21 DEGs according to systems
biology classifications38,39 revealed the same deregulated
SkM networks (Figure 7d) as for the E16.5 DEGs (Figure 4c).
At P21, however, the networks contained more DEGs than at
E16.5, and we identified additional networks ('hypertrophy &
atrophy pathways' and 'cytoskeleton'). Of note, the strong
increase in deregulated genes including collagen isoforms in
the network 'extracellular matrix (ECM)' (Figure 7d) correlates
with fibrosis detected in the TA of adult Spin1M5 mice
(Supplementary Figure 5d). Together, this analysis provided
a comprehensive disease signature for the TA of surviving
Spin1M5 mice.
Differential gene expression in surviving Spin1M5 mice
correlates with SkM disease patterns. In the final set of
experiments, we aimed to correlate differential gene expres-
sion in surviving Spin1M5 mice with SkM disease patterns.
Since several P21 DEGs encode titin-associated
proteins21,22 (Figure 7d, network 'Ttn-associated'), we
hypothesized similarity with diseases caused by Ttn muta-
tions such as tibial muscular dystrophy (TMD).44,45 Muscular
dystrophy with myositis (mdm) mice (serving as a model of
TMD) express a titin mutant lacking the N2A region, which
binds Ankrd1, Ankrd2, and Ankrd23. Accordingly, defective
Ankrd1 signaling has been implicated in TMD in mdm mice.46
Intersection of the P21 DEGs with 75 DEGs previously
reported in mdm mice46 revealed a significant overlap of 26
genes (Figure 8a). Given that Ankrd1 and Ankrd2 are already
deregulated in Spin1M5 fetuses at E16.5 (Figures 3c and 4c),
aberrant expression of titin-associated proteins may account
for SkM defects in Spin1M5 mice.
Next, we observed downregulation of genes involved in
glycogen metabolism including Pygm, Pfkm, Phka1, Phkg1,
Prkaa2, andPrkag3 (Figure 7d, networks 'glucose & glycogen'
metabolism and 'hypertrophy & atrophy pathways'). Mutations
of these genes are known to occur in glycogen storage
diseases (glycogenoses).28 Periodic acid–Schiff (PAS) stain-
ing revealed abnormal glycogen deposits in TA and soleus
fibers of Spin1M5 mice (Figure 8b, black triangles). Although
these deposits are limited to individual fibers, which differs
from typical glycogenoses, our observation suggests that
defective glycogen metabolism contributes to SkM disease in
adult Spin1M5 mice.
Finally, we noted strong deregulation of acetylcholine
receptor subunits (Chrna1, Chrnd, Chrne, Chrng) and several
genes involved in excitation-contraction coupling (Figure 7d,
networks 'NMJ' and 'ECC') hinting at defective neuromuscular
junctions and/or excitation-contraction coupling. Therefore,
we analyzed neuromuscular junctions in the diaphragm of
newborn and adult Spin1M5 mice by electron microscopy
(Figure 8c). At both time points, the analysis revealed defects
of the synaptic membrane (white triangles) and an abnormal
appearance as well as a reduced number of synaptic vesicles
(arrows) in Spin1M5 mice (Figure 8c). Furthermore, we
observed the presence of vacuoles at nerve terminals of adult
Spin1M5 mice (Figure 8c, right columns (asterisks)). These
data provide evidence for neuromuscular junction damage
and abnormal excitation-contraction coupling in Spin1M5mice.
Figure 6 Surviving Spin1M5 mice exhibit major defects in soleus, tibialis anterior, and diaphragm. (a,b) Appearance (a) and average body weight (b) of Spin1M5 and control
mice (n= 5 females in each category) at 30 weeks of age. Error bars represent +S.D., **Po0.01. (c) Degeneration of the soleus (SOL) muscle in adult Spin1M5 compared with
control mice exemplified at 16 weeks of age. (d) Hind limb muscles (gastrocnemius (GC), plantaris (PL), soleus, tibialis anterior (TA), extensor digitorum longus (EDL), and
quadriceps (QC)) of Spin1M5 and control mice at 30 weeks of age. Arrows point at the soleus embedded in gastrocnemius and plantaris, which is visible in control but degenerated
in Spin1M5 mice. (e) Hematoxylin & eosin (H&E) staining of gastrocnemius, soleus, TA, and EDL muscle of Spin1M5 and control mice at 30 weeks of age. (f) Fiber types in
glycolytic (white) or oxidative (red) parts of the TA of Spin1M5 and control mice at 15 weeks of age (top and middle rows) observed by immunofluorescence (IF) staining. Tissue
sections were stained with selective antibody directed against MHC-I (purple), MHC-IIb (cyan), MHC-IIa (red), and MHC-IIx (green). For comparison, NADH staining was included
(bottom row). Fibers with abnormal NADH staining are marked with arrows. Corresponding fibers in each column of images are squared
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Figure 7 Identification of deregulated SkM functional networks in surviving Spin1M5 mice. (a) Intersection of DEGs observed for TA of Spin1M5 mice at P21 (blue) and SkM at
E16.5 (red). (R: enrichment factor; p: P-value calculated for the intersection.) (b,c) Phenotype (b) and pathway (c) analysis for the set of 1040 DEGs observed in the TA of Spin1M5
mice at P21. For the phenotype analysis, the ‘top 5’ non-redundant terms are depicted. (d) Assignment of selected P21 DEGs identified by phenotype and pathway analyses to
functional SkM networks. Upregulated DEGs are depicted in red, downregulated in blue color (fold change in brackets)
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Discussion
In this study, we ablated the H3K4me3 reader Spin1 in
myoblast precursors resulting in abnormal fetal myogenesis,
early postnatal death, or severe SkM defects in few survi-
ving Spin1M5 mice. Our analyses suggest that numerous
E16.5 DEGs are direct target genes of Spin1 and Myod1.
Furthermore, aberrant expression of Myf5, Myog, Msc,
and Hes6 in Spin1M5 fetuses may indirectly affect Myod1-
dependent gene regulation. Msc, for example, can repress
transcription and antagonize the action of Myod1 in undiffer-
entiated myoblasts by heterodimerization with E-proteins.40
Hes6 was reported to inhibit expression of Msc thereby
enhancing myoblast differentiation.43 Therefore, deregu-
lated bHLH transcription factor networks appear to deter-
mine, at least in part, aberrant gene expression in Spin1M5
fetuses.
The preferential degeneration of soleus, TA, and diaphragm
in adult Spin1M5 mice raised the question whether this is
caused by fiber type- or muscle type-selective mechanisms.
Currently, we favor the latter hypothesis. While degeneration
of type I and type II fibers might account for soleus defects, it
would not convincingly explain the severe TA damage since
this muscle contains only about 1 and 10% of these fibers
types, respectively.47 Furthermore, at E15.5 or E16.5, we did
not identify DEGs involved in the regulation of fiber type
identity or plasticity (e.g., Six1, Six4, Eya1, Sox6).30
One possible determinant of muscle type-selective degen-
eration in Spin1M5 mice could be the deregulation of titin-
associated proteins such as Ankrd1, which has been linked
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Figure 8 Differential gene expression in surviving Spin1M5 mice correlates with SkM disease patterns. (a) Intersection of DEGs observed for the TA of Spin1M5 mice at
P21 (blue) and SkM ofmdm mice46 (gray) representing a model for tibial muscular dystrophy (TMD) (R: enrichment factor; p: P-value calculated for the intersection). (b) Periodic
acid–Schiff (PAS) staining for glycogen accumulation in TA and soleus muscle (SOL) of Spin1M5 and control mice at 30 weeks of age. Fibers showing abnormal glycogen
accumulation are marked with black triangles. (c) Electron microscopy (EM) images of neuromuscular junctions in the diaphragm (DP) of newborn and 15-week-old Spin1M5 and
control mice. Membranes at the synaptic cleft are marked with white triangles, synaptic vesicles with arrows, and vacuoles observed at neuromuscular junctions of Spin1M5 mice
with asterisks
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with TMD in mdm mice.46 However, despite some similarity
with TMD, the SkM phenotype of Spin1M5 mice is apparently
more complex. We exemplarily correlated the P21 DEGs with
abnormal glycogen accumulation in individual TA and soleus
fibers as well as neuromuscular junction defects in Spin1M5
mice. Due to the high number of DEGs observed in the TA of
Spin1M5 mice at P21, these examples only provide an initial
characterization of deregulated SkM networks.
Compared with transcription factors, signaling molecules,
SkM structural proteins, or metabolic enzymes, the roles of
epigenetic regulators in SkM physiology and disease have
only more recently become a focus of research. However,
while epigenetic writers, erasers, and non-coding RNAs have
received considerable attention,48,49 little is known about
potential functions of histone code readers in SkM. Few
readers (Brd4, Ing2, Sfmbt1, Dpf3) have been implicated in
myogenesis using the C2C12 cell culture model50–53 or in
zebrafish.54 However, in these cases either knockout mouse
models have not been reported, or in mice no apparent SkM
phenotype was observed.55–57 Thus, to the best of our
knowledge, Spin1 is the first histone code reader, for which
ablation in SkM has fatal consequences in mice. Together, our
histological and transcriptome analyses provide insight into
severe SkM defects in Spin1M5 fetuses and surviving adult
mice, hinting at Spin1 as a potential player in human SkM
disease.
Materials and Methods
Mouse studies. All mice were housed in the pathogen-free barrier facility of the
University Medical Center Freiburg in accordance with institutional guidelines and
approved by the regional board. Mice were maintained under temperature- and
humidity-controlled conditions with a 12-h light/dark cycle, free access to water, and
a standard rodent chow (3807, Provimi Kliba). Animals were killed by cervical
dislocation and tissues immediately processed for further analyses.
Generation and validation of Spin1R26 and Spin1M5 mice. The
targeting strategy for generation of a conditional Spin1 allele is outlined in
Supplementary Figure 1a. Details are available upon request. The targeting
construct was electroporated into C57BL/6 N Tac embryonic stem (ES) cells
(Taconic), and neomycin-and puromycin-resistant clones were expanded. Selected
ES cells were injected into blastocysts of C57BL/6 N mice. Resulting mice were
bred to Rosa26-Flp mice to remove NeoR and PuroR selection markers. Offspring
harbored a conditional Spin1 allele, in which exon 4 of Spin1 was flanked by loxP
sites. C57/Bl6N mice homozygous for the conditional allele (Spin1p/p) were crossed
with the Rosa26-Cre deleter strain32 to generate ubiquitous knockout (Spin1R26)
mice or with the Myf5-Cre deleter strain31 to selectively ablate Spin1 in myoblast
and brown adipocyte precursors (Spin1M5 mice). Mice were maintained on the C57/
Bl6N background. In phenotypic analyses of Spin1M5 mice, Spin1+/p or Spin1p/p
littermates served as controls. Mice were genotyped by PCR amplification using
GoTaq G2 Flexi DNA polymerase (Promega) of genomic DNA extracted from tail
biopsies with the NucleoSpin 96 tissue kit (Macherey Nagel). The following
genotyping primers were used: forward 5-ATAGGCTCTCTGGCATGGTG-3 / reverse
5-ACAGCGTGACACATCAAAGC-3 detecting the wild-type (177 bp) and the
conditional (337 bp) allele and forward 5′-GGAGGAAGACACCTAATAGCACC-3′
/reverse 5′-AAGGCAAAACGGAGACAGC-3′ detecting the deleted allele (395 bp).
Efficient Spin1 depletion in myogenic cells and remaining Spin1 expression in non-
myogenic cells of Spin1M5 mice was validated as follows. Spin1M5 and control mice
were crossed with mice harboring a green fluorescent protein/nuclear lacZ (GNZ)
reporter.58 In mice harboring the reporter, GNZ expression is Cre dependent. GNZ-
positive myogenic cells in Spin1M5 mice did not express Spin1, whereas Spin1-
positive cells were GNZ-negative and therefore non-myogenic (Supplementary
Figure 1f). Part of these Spin1-expressing, non-myogenic cells were Tcf4-positive
fibroblasts34 (Supplementary Figure 1e). Reduction of Spin1 mRNA in hind limb
muscle of newborn Spin1M5 mice was confirmed by quantitative RT-PCR
(Supplementary Figure 1g).
Quantitative RT-PCR and RNA sequencing. SkM tissue was homo-
genized in TRIzol reagent (Life Technologies, Darmstadt, Germany) using a Minilys
personal homogenizer (Bertin, Montigny, France) and 0.5 or 2.0 ml CK14 lysing kits
(Precellys, Montigny, France). RNA was isolated using a standard phenol/chloroform
extraction protocol. cDNA was prepared by reverse transcription of total RNA using
SuperScript II (Life Technologies) and oligo(dT) primer according to the supplier’s
protocol. Quantitative RT-PCR was performed with a Lightcycler 480 II (Roche,
Mannheim, Germany) using Absolute SYBR green ROX Mix (Thermo Scientific,
Scherte, Germany) and the following primers: Spin1 (exon 4, forward) 5′-
CAGGTGCCTGTGAATCCTTC-3′, Spin1 (exon 5, reverse) 5′-ACATGTGC
TCCACTGCTTTG-3′, Tbp (forward) 5′-CCCCTTGTACCCTTCACCAAT-3′, Tbp
(reverse) GAAGCTGCGGTACAATTCCAG-3′, Hprt (forward) 5′-GTTAAGC
AGTACAGCCCCAAA-3′, Hprt (reverse) 5′-AGGGCATATCCAACAACAAACTT-3′,
Polr2a (forward) 5′-CACCCCAGCTTCTCCCAAAT-3′, and Polr2a (reverse) 5′-
AGTATGTCGGGGAGGTTGGA-3′. Data were analyzed using the 2(-Delta Delta C
(T)) method.59
RNA-seq analyses for E15.5 and E16.5 were performed with SkM dissected from
front and hind limb of three Spin1M5 and four control fetuses. For RNA-seq analysis of
mice at three weeks of age (P21), TA isolated from four Spin1M5 and four control mice
was used. RNA was isolated as described above, except that minced tissue in TRIzol
was further homogenized with QIA shredder spin columns (Qiagen, Hilden,
Germany). RNA quality was determined using the RNA 6000 Nano Kit (Agilent,
Waldbronn, Germany) on an Agilent 2100 Bioanalyzer. RNA with a RIN above 8.0
was sequenced at the DKFZ core facility (Heidelberg, Germany) or the Deep
Sequencing Unit (Max-Planck-Institute of Immunology and Epigenetics, Freiburg)
using the standard Illumina protocol. Paired-end reads were mapped to Ensemble
annotation NCBIm38/mm10 with TopHat260 using default parameters. The aligned
reads were counted with HOMER software61 and DEGs calculated with edgeR.62
Overrepresentation analyses for the identified DEGs (P≤ 1e− 3 (E15.5 and E16.5),
P≤ 1e− 5 (P21); fold change ≥ 1.5;≥ 50 reads in all Spin1M5 or all control samples]
were performed using WebGestalt36 with 'genome' as reference set.
Of note, none of the RNA-seq analyses identified Spin1 as differentially expressed
gene. Examination of the normalized reads at exons 1 to 6 of the Spin1 gene
explained this observation (Supplementary Table 1e). Reads were significantly
decreased at exon 4 (which is excised in a Myf5-Cre-dependent manner in myogenic
cells), but not at other exons in Spin1M5 relative to control mice. Thus, in myogenic
cells of Spin1M5 mice a truncated transcript (lacking exon 4) is expressed, which
results in translation of a truncated Spin1 peptide (containing 56 N-terminal amino
acids lacking any known functional domain) due to the presence of a premature
STOP codon in exon 5. Normal Spin1 transcript (containing exon 4) present in SkM of
Spin1M5 mice is most likely produced by non-myogenic cells (Supplementary Figures
1e and f). Since mapped reads at all exons contribute to the overall count, differential
expression of Spin1 is not detected in RNA-seq analyses.
Antibodies. The generation and validation of anti-SPIN1 antibodies 5865 and
5867 was described previously.6 Antibodies SPIN1(5867) and H3K4me3
(Diagenode, Oxford, UK, C15410003) were used for ChIP. For immunofluorescence
staining the following primary antibodies were used: SPIN1(5865) 1 μg/ml; Pax7
(PAX7, DSHB, batch 7/2/15) 2 μg/ml; Tcf4 (6H5-3, Millipore, Darmstadt, Germany,
05-511, batch 2155406) 10 μg/ml; Ankrd1 (Proteintech Group, Manchester, UK,
11427-1-AP, batch 1951) 1:100; Ankrd2 (Proteintech Group, 11821-1-AP, batch
7649) 1:100; dystrophin (Abcam, Cambridge, UK, ab15277, batch GR226781-6)
1:500; MHC-I (NOQ7.5.4D, Sigma, Munich, Germany, M8421, batch 035M4792V)
1:2000; MHC-IIa (SC-71, DSHB, batch 4/7/16) 1:10; MHC-IIx (6H1, DSHB, batch
3/3/16) 1:6; MHC-IIb (BF-F3, DSHB, batch 5/12/16) 1:20; MCH, skeletal, fast
(MY-32, Sigma, M4276, batch 083M4790V) 1:1000; GNZ (anti-GFP, Abcam,
ab13970, batch GR236651) 1:1000; normal rabbit IgG (Santa Cruz, Heidelberg,
Germany, sc-2027). The following secondary antibodies were used: Alexa Fluor 488
(goat anti-mouse IgM, Molecular Probes, Karlsruhe, Germany, A21042, batch
1387726) 1:600; Alexa Fluor 488 (goat anti-mouse IgG, Molecular Probes, A11029,
batch 1306597) 1:600; Alexa Fluor 546 (goat anti-mouse IgG, Molecular Probes,
11030, batch 517979) 1:600; Alexa Fluor 594 (goat anti-chicken IgG, Molecular
Probes, A11042, batch 762712) 1:600; donkey anti-rabbit IgG-HRP (Santa Cruz, sc-
2313) 1:500.
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Immunofluorescence staining. SkM tissues were either fixed in 4%
paraformaldehyde/PBS or flash-frozen in 2-methylbutane (Sigma). Paraffin sections
(5 μm) were deparaffinized, heated in antigen retrieval solution (20 mM Tris (pH9.0))
for 20 min in a pressure cooker, and blocked for 1 h at room temperature in 3%
skim milk powder/PBS containing 0.1% Tween (PBST). Cryosections (10 μm) were
blocked with 5% fetal calf serum/PBST. Sections were incubated overnight
with primary antibody at 4 °C, washed with PBST, incubated with secondary
antibody for 1 h at room temperature, and then washed with PBST. For Spin1
staining, signal amplification using the TSA fluorescein system (Perkin Elmer,
NEL701A001KT) was applied according to the manufacturer’s instructions. Briefly,
tissue sections were blocked in 0.5% TNB blocking buffer, labeled with primary and
secondary antibody, and then incubated with TSA reagent for 15 minutes at room
temperature followed by two washing steps with PBST. Finally, nuclei were stained
with DAPI (1 μg/ml) followed by two washing steps with PBST, and sections were
mounted using Fluoromount-G (SouthernBiotech). Images were recorded with a
confocal microscope (Leica TCS SP2 AOBS). Counting was done with ImageJ63
followed by visual validation of the results. Pax7-positive nuclei or nuclei of
myofibers (expressing Spin1 or being Spin1-negative) were quantified using
confocal images with dimensions of 187.5 μm× 187.5 μm or 375 μm× 375 μm,
respectively.
Isolation of primary myoblasts and ChIP sequencing. Primary
myoblasts were isolated from 10- day-old C57BL/6 N mice using an established
preplating protocol.64 Briefly, limb muscles were collected from front and hind leg,
minced, digested for 1 h in 0.2% collagenase type I (Sigma, C0130), and filtered
through 100 μm cell strainers (Falcon, 352360). Cells were collected by
centrifugation, resuspended in DMEM medium (Gibco, Schwerte, Germany,
11995-065) supplemented with 10% FCS, 10% horse serum, and 1.25% chicken
embryo extract (Seralab, CE-650-J), and cultivated for 1 h on 6 cm tissue culture
dishes to allow for attachment of fibroblasts. Supernatants were transferred to 6 cm
dishes, again incubated for one hour, and then transferred to 10 cm tissue culture
dishes coated with collagen (Gibco, A10483-01). Myoblasts were cultivated for 3 to
4 days until a confluency of about 70% was reached. Cells were fixed with 1%
formaldehyde for 5 minutes, quenched in glycine (1.25 M), washed with PBS buffer,
collected, and snap-frozen in liquid nitrogen.
Chromatin was prepared using the NEXSON procedure.65 Briefly, nuclei were
extracted by sonication with a Covaris E220 sonicator (75 W peak power, 2% duty
factor, 200 cycles/burst, 60 s). Nuclei were pelleted, resuspended in 1 ml of shearing
buffer, and sonicated for 12 min (140 W peak power, 5% duty factor, 200 cycles/
burst). Chromatin was diluted 1:2 in buffer H (Diagenode auto histone ChIP-seq kit
(C01010022)) before ChIP. For ChIP, one tenth of the chromatin was incubated with
1 μg of H3K4me3 antibody (Diagenode, C15410003). The remaining chromatin (from
~ 1.2 million cells) was incubated with 5 μg of SPIN1(5867) antibody. ChIP was
performed using the automated platform SX-8G IP-Star (Diagenode) and the
program 'ChIP indirect method'. Chromatin was incubated with antibody for 10 h
followed by 3 h of incubation with protein A-conjugated beads. 1% of the original
chromatin was used as input. After elution from beads, ChIP and input samples were
reverse crosslinked, and DNA purified with MinElute columns (Qiagen, 28004).
Libraries were prepared using the NEBNext Ultra DNA library preparation kit (NEB,
E7370S) according to the manufacturer’s instruction and without size selection.
Adapter-ligated fragments were amplified with 12 PCR cycles and sequenced on the
Illumina HiSeq 2500 platform by the Deep Sequencing Unit of the Max-Planck-
Institute of Immunology and Epigenetics (Freiburg).
Paired-end reads were mapped to the mouse reference genome (mm10)
using bowtie 266 with default parameters. Data were further analyzed using the peak
finding algorithm of MACS 1.4.267 using input as control. All peaks with a false
discovery rate41% were excluded from further analyses. The uniquely mapped reads
were used to generate genome-wide intensity profiles, which were visualized using the
integrative genomics viewer (IGV).68 Peaks were annotated and overlaps between
different peak files were calculated with HOMER.61 The genomic features (promoter,
exon, intron, 5′ or 3′ untranslated region, and intergenic region) were defined and
calculated using Refseq and HOMER. Myod1 chromatin association in C2C12
myoblasts was analyzed using a previously deposited GEO data set (GSE36024). Venn
diagrams were generated with the help of Venny.69 Intensity profiles for Spin1 and
H3K4me3 gene promoter occupancy were analyzed with SeqMINER.70
GEO data availability. The RNA and DNA sequencing data discussed in this
publication have been deposited in NCBI's Gene Expression Omnibus71 and are
accessible through GEO Series accession number GSE92539.
Electron microscopy. Muscle samples were fixed by immersion in 2.5%
glutaraldehyde and 2.5% paraformaldehyde in cacodylate buffer (0.1 M, pH 7.4) and
then washed in cacodylate buffer for further 30 min. The samples were post-fixed in
1% osmium tetroxide in 0.1 M cacodylate buffer for 1 h at 4 °C, and dehydrated in
an ascending ethanol gradient (50, 70, 90, and 100%) and propylene oxide for
30 min each. Samples were embedded in Epon 812 substitute (Sigma-Aldrich).
Semi-thin sections cut at 2 μm and ultra-thin sections cut at 70 nm were contrasted
with uranyl acetate and lead citrate and examined at 70 kV with a Morgagni 268D
electron microscope. Images were digitally captured by Mega View III camera (Soft
Imaging System).
Hematoxylin & eosin staining. Deparaffinized and rehydrated or flash-
frozen tissue sections (5 or 10 μm, respectively) were stained according to a
standard protocol with hematoxylin (Gill No. 3, Sigma, GHS332) and eosin Y
solution (Sigma, HT110332) and mounted using Roti-Histokitt (Roth).
Gomori trichrome staining. Deparaffinized and rehydrated tissue sections
(5 μm) were stained using Bouin’s solution (Sigma, HT10132), hematoxylin-
Weigert’s iron kit (Dianova, HWI-2), and trichrome stain (blue) solution (Dianova,
TGB500) according to the supplier's instructions and mounted using Roti-Histokitt
(Roth).
NADH staining. Cryosections (10 μm) were incubated with staining solution
(0.2 M Tris (pH 7.4), 1.5 mM NADH (Roche, 10128015001), 1.5 mM nitroblue
tetrazolium (Sigma, N-6876)), dehydrated in an ascending ethanol gradient,
incubated twice with xylene, and mounted using Roti-Histokitt (Roth).
Periodic acid–Schiff staining. Deparaffinized and rehydrated tissue
sections (5 μm) were treated with 0.5% periodic acid solution (Sigma, 3951),
stained with Schiff’s reagent (Sigma, 3952016), dehydrated, and mounted using
Roti-Histokitt (Roth).
Statistics. Transcriptome and cistrome data were analyzed as described above.
Statistical significance of gene set intersections was evaluated by a hypergeometric
test using the program 'R' (http://www.R-project.org) [phyper (N12-1, N1, N-N1, N2,
lower.tail= FALSE) with N1 (genes in set 1), N2 (genes in set 2), N12 (genes in
intersection), and N (genome size)]. The enrichment factor (R) was calculated
according to R= (N × N12)/(N1 × N2). Other data are presented as the mean value
or percentage change +S.D. Comparisons between two data sets were made using
the two-tailed Student's t-test for parametric data and the Wilcoxon signed-rank test
for nonparametric data. A P-value of less than 0.05 was considered statistically
significant. Statistical significance is indicated as follows: *Po0.05, **Po0.01,
***Po0.001.
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